Drug-discovery

AB SCIEX is a global leader and trusted partner in the development of advanced analytical technologies that help answer complex scientific challenges in the life sciences.

Our mass spectrometry solutions come from a strong heritage of innovative technologies, which have paved the way for the development of intelligent, efficient, and advanced analytical workflows that continue to redefine LC/MS/MS.

AB SCIEX technology is central to the drug discovery and development pipeline. From the rapid structural identification and in vitro metabolic stability needs of the Early Discovery phase, through to the integrated Qual/Quant and low-level quantitation requirements of the Development phase, AB SCIEX offers an innovative set of chromatography, mass spectrometry, software, and compliance and validation solutions to meet the demands of modern therapeutic drug development.

Drug Discovery Pipeline

Get the information you need, faster, earlier, and with greater confidence to take discovery products from the lab to the clinic with integrated workflows.